Pediatric Dermatology

Study seeks to define metastatic risk factors of select patients

General symptoms, pain, burning reduced with reports of only minimal side effects

New Orleans - Following treatment with IV- or IM-administered alefacept (Amevive), more than 1,000 patients with chronic plaque psoriasis showed insignificant levels of drug-related antibody.

Veteran derms tell fledgling colleagues to suck it up

One change is the repeal of the requirement that professionals obtain patients' written consent for disclosing information, payment, or other purposes

New Orleans - True protection from the sun does not rely on sunscreens but is a comprehensive plan of photo-avoidance.

The chief forensic toxicologist who ruled that no Accutane (isotretinoin) was present in the body of deceased suicidal teen Charles Bishop confirmed that enough blood was present in his body during tests to validate the investigation.

The drug that pleases by paralysis is no reason to party, even in the wake of FDA approval.

Cold winds and dry indoor heating can be tough on your skin.

New Orleans - Timing is key for a successful outcome when performing dermatologic surgery in pediatric patients, and lesion size and location are the two most important variables factoring into the equation, Annette M. Wagner, M.D., said at the annual meeting of the American Academy of Dermatology.

New Orleans - Systemic contact dermatitis may present with a variety of eczematous and noneczematous cutaneous reaction patterns and may be an overlooked diagnosis unless clinicians maintain an index of suspicion that systemic exposure to a contact allergen is driving the skin eruption, Donald V. Belsito, M.D., said at the annual meeting of the American Academy of Dermatology.

New Orleans - The experiences of an expanding series of patients indicate infliximab (Remicade) is a valuable therapy for the management of pyoderma gangrenosum (PG), Marketa Limova, M.D., said at the annual meeting of the American Academy of Dermatology.

Atlanta -- The so-called mystery rash is getting more mysterious. In fact, the Centers for Disease Control and Prevention says the hubbub played up in local and national media might be unfounded.

New Orleans - Tacrolimus ointment (Protopic) shows promise as an innovative new topical treatment for vitiligo, Pearl E. Grimes, M.D., said at the annual meeting of the American Academy of Dermatology.

Dealing with epidermis

New Orleans - In an overview of tests needed to diagnose patients with cutaneous manifestations of collagen vascular disease,

Rochester, Minn. - Could you identify a life-threatening rash in your next patient?

New Orleans - A study demonstrating the importance of the development and functions of the stratum corneum acid mantle in adult murine and neonatal rat models may have important implications for developing therapies for humans.

New Orleans - Be alert for the signs of peripheral vascular disease, Anna Falabella, M.D., said at the annual meeting of the American Academy of Dermatology.

Products and procedures designed to advance the practice of cosmetic dermatology flooded our specialty during the past five years

Los Angeles -- Diabetic ulcers can be reduced or even eliminated by correcting abnormal biomechanics of the feet, including a tight Achilles tendon and limited motion of the great toe, researchers said at the annual meeting of the American College of Foot and Ankle Surgeons

Dermatologists and other isotretinoin (Accutane) prescribers soon will be mailed a new brochure on how to recognize psychiatric disorders in the pediatric population.

Postmenopausal Women Encouraged to Take Another Look at HRT through National Medical Research Study

Keeping a little 'up the sleeve' when applying local anesthesia maximizesefficacy and episode outcomesNew Orleans - Attention to scheduling and techniques for localanesthesia delivery and suturing are important in making dermatologic surgerya favorable experience for children and achieving an optimal cosmetic result,said Annette M. Wagner, M.D., at the annual meeting of the American Academyof Dermatology.

Physicians should consider substances etiology for patients in clinicalremission or with family history